TTF1 and pancreatic neuroendocrine tumor: Our rate of TTF-1 positivity in 5.4% of 93 pancreatic NETs is close to the 7% of 44 described by Tseng et al. [42] while Koo et al. [54] had not found TTF-1 expression in a series of 33 cases.